We observed a reduced tumor burden in mice grafted with shMPST-PDC, compared to mice grafted with shControl-PDC up to the experiment end-points (Figs. 5e and S6L), and a 1.6-fold increase in the median survival expectancy of mice xenografted with shMPST-PDC (Fig. 5f). Here, PDC is linked to neoplasm.